$859 Million is the total value of First Light Asset Management, LLC's 71 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 8.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MODN | Buy | MODEL N INC | $70,441,000 | -3.3% | 2,753,758 | +1.7% | 8.20% | +27.6% |
| ATRC | Buy | ATRICURE INC | $60,458,000 | -32.5% | 1,479,626 | +8.4% | 7.04% | -11.0% |
| PRTA | Buy | PROTHENA CORPORATION PLC | $52,622,000 | -21.7% | 1,938,183 | +5.4% | 6.12% | +3.3% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $41,415,000 | -35.0% | 941,245 | -41.1% | 4.82% | -14.2% |
| SPNE | Buy | SEASPINE HOLDINGS CORP | $39,721,000 | -53.4% | 7,030,309 | +0.4% | 4.62% | -38.5% |
| OMCL | Buy | OMNICELL INC | $39,475,000 | -5.3% | 347,029 | +7.9% | 4.59% | +25.0% |
| KRYS | Sell | KRYSTAL BIOTECH INC | $39,108,000 | -18.1% | 595,612 | -17.0% | 4.55% | +8.0% |
| CUTR | Sell | CUTERA INC | $28,943,000 | -45.8% | 771,814 | -0.3% | 3.37% | -28.5% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $27,675,000 | -45.3% | 467,555 | +7.4% | 3.22% | -27.9% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL INC | $26,994,000 | -15.0% | 452,470 | +3.4% | 3.14% | +12.1% |
| SIBN | Buy | SI-BONE INC | $26,483,000 | +8.0% | 2,006,304 | +85.0% | 3.08% | +42.6% |
| AXGN | Buy | AXOGEN INC | $24,776,000 | +28.8% | 3,025,119 | +24.8% | 2.88% | +69.9% |
| CRNX | Buy | CRINETICS PHARMACEUTICALS INC | $23,137,000 | +80.9% | 1,240,609 | +112.9% | 2.69% | +138.7% |
| BLU | Sell | BELLUS HEALTH INC | $22,251,000 | +29.8% | 2,408,074 | -3.3% | 2.59% | +71.2% |
| NEO | Buy | NEOGENOMICS INC | $22,131,000 | +126.0% | 2,715,487 | +236.9% | 2.58% | +198.0% |
| Buy | PARAGON 28 INC | $19,639,000 | +4.9% | 1,237,511 | +10.6% | 2.28% | +38.3% | |
| ATEC | Buy | ALPHATEC HOLDINGS INC | $19,129,000 | -38.8% | 2,924,964 | +7.6% | 2.23% | -19.3% |
| AXNX | Buy | AXONICS MODULATION TECHNOLOGIES | $17,795,000 | +1.7% | 314,004 | +12.3% | 2.07% | +34.2% |
| CDNA | Buy | CAREDX INC | $16,682,000 | -37.5% | 776,620 | +7.6% | 1.94% | -17.6% |
| KROS | Sell | KEROS THERAPEUTICS INC | $16,532,000 | -53.8% | 598,333 | -9.1% | 1.92% | -39.1% |
| HCAT | Buy | HEALTH CATALYST INC | $16,449,000 | -26.7% | 1,135,165 | +32.2% | 1.91% | -3.3% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $15,914,000 | +7.4% | 125,793 | +7.6% | 1.85% | +41.7% |
| KRMD | Buy | REPRO-MED SYSTEMS INC | $15,440,000 | -11.5% | 6,102,934 | +0.1% | 1.80% | +16.8% |
| INSM | Buy | INSMED INC | $15,030,000 | -13.3% | 762,182 | +3.3% | 1.75% | +14.4% |
| NGM | Buy | NGM BIOPHARMACEUTICALS INC | $14,562,000 | +16.9% | 1,135,884 | +39.1% | 1.69% | +54.3% |
| KIDS | Buy | ORTHOPEDIATRICS CORP | $13,580,000 | -0.2% | 314,724 | +24.8% | 1.58% | +31.7% |
| PFMT | Sell | PERFORMANT FINANCIAL CORPORATION | $13,202,000 | -15.9% | 5,019,777 | -0.6% | 1.54% | +10.9% |
| BCYC | Sell | BICYCLE THERAPEUTICS PLC | $11,818,000 | -69.7% | 704,282 | -20.9% | 1.38% | -60.1% |
| TPTX | Sell | TURNING POINT THERAPEUTICS | $10,595,000 | +89.1% | 140,801 | -32.5% | 1.23% | +149.6% |
| OPRX | Buy | OPTIMIZERX CORP | $9,881,000 | -20.7% | 360,761 | +9.1% | 1.15% | +4.6% |
| BVS | Buy | BIOVENTUS INC | $9,196,000 | -27.7% | 1,348,460 | +49.6% | 1.07% | -4.5% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $8,686,000 | +21.0% | 104,813 | +12.6% | 1.01% | +59.7% |
| PFE | Sell | PFIZER INC | $7,673,000 | +0.7% | 146,356 | -0.6% | 0.89% | +32.9% |
| CDXS | Sell | CODEXIS INC | $7,167,000 | -58.1% | 685,213 | -17.4% | 0.83% | -44.8% |
| Sell | MAXCYTE INC | $6,241,000 | -32.4% | 1,319,489 | -0.1% | 0.73% | -10.9% | |
| PLRX | Buy | PLIANT THERAPEUTICS INC | $6,163,000 | +113.8% | 769,370 | +87.0% | 0.72% | +182.3% |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $5,404,000 | +14.1% | 277,674 | +29.1% | 0.63% | +50.5% |
| GMAB | Sell | GENMAB AS | $5,227,000 | -10.8% | 160,885 | -0.6% | 0.61% | +17.6% |
| SLP | Sell | SIMULATIONS PLUS INC | $3,748,000 | -3.8% | 75,985 | -0.6% | 0.44% | +26.7% |
| ABCM | Sell | ABCAM PLC | $3,193,000 | -21.9% | 220,838 | -1.1% | 0.37% | +3.3% |
| NARI | Sell | INARI MEDICAL INC. | $3,062,000 | -25.6% | 45,029 | -0.8% | 0.36% | -1.9% |
| IWO | New | ISHARES RUSSELL 2000 GROWTH ETF | $2,732,000 | – | 13,242 | +100.0% | 0.32% | – |
| LHCG | Sell | LHC GROUP INC | $2,397,000 | -8.3% | 15,392 | -0.7% | 0.28% | +21.3% |
| Buy | AKUMIN INC | $2,257,000 | -45.2% | 3,764,264 | +1.5% | 0.26% | -27.5% | |
| MIRO | Buy | MIROMATRIX MEDICAL INC | $2,059,000 | +1.5% | 516,007 | +0.7% | 0.24% | +34.1% |
| SIEN | Sell | SIENTRA INC | $1,199,000 | -69.8% | 1,431,387 | -20.0% | 0.14% | -60.0% |
| ANTM | ELEVANCE HEALTH INC | $600,000 | -1.8% | 1,244 | 0.0% | 0.07% | +29.6% | |
| UTHR | UNITED THERAPEUTICS CORP DEL | $581,000 | +31.4% | 2,466 | 0.0% | 0.07% | +74.4% | |
| ABBV | ABBVIE | $573,000 | -5.4% | 3,740 | 0.0% | 0.07% | +26.4% | |
| BMY | BRISTOL-MYERS SQUIBB CO | $559,000 | +5.5% | 7,256 | 0.0% | 0.06% | +38.3% | |
| GSK | GLAXOSMITHKLINE PLC | $547,000 | -0.2% | 12,574 | 0.0% | 0.06% | +33.3% | |
| CI | CIGNA CORPORATION | $512,000 | +9.9% | 1,943 | 0.0% | 0.06% | +46.3% | |
| CVS | CVS HEALTH CORPORATION | $511,000 | -8.6% | 5,519 | 0.0% | 0.06% | +20.4% | |
| WAT | WATERS CORPORATION | $508,000 | +6.5% | 1,536 | 0.0% | 0.06% | +40.5% | |
| HUM | HUMANA INC | $500,000 | +7.5% | 1,068 | 0.0% | 0.06% | +41.5% | |
| BDX | BECTON DICKINSON AND CO | $465,000 | -7.4% | 1,888 | 0.0% | 0.05% | +22.7% | |
| AVTR | AVANTOR INC | $454,000 | -8.1% | 14,596 | 0.0% | 0.05% | +20.5% | |
| NVST | ENVISTA HOLDINGS CORP | $455,000 | -20.7% | 11,793 | 0.0% | 0.05% | +3.9% | |
| MCK | MCKESSON CORP | $439,000 | +6.6% | 1,346 | 0.0% | 0.05% | +41.7% | |
| GILD | GILEAD SCIENCES INC | $414,000 | +3.8% | 6,705 | 0.0% | 0.05% | +37.1% | |
| SYNH | SYNEOS HEALTH INC CLASS A | $411,000 | -11.4% | 5,736 | 0.0% | 0.05% | +17.1% | |
| ITGR | INTEGER HOLDINGS CORPORATION | $413,000 | -12.3% | 5,846 | 0.0% | 0.05% | +14.3% | |
| HOLX | HOLOGIC INC | $405,000 | -9.8% | 5,845 | 0.0% | 0.05% | +17.5% | |
| PRGO | PERRIGO COMPANY | $399,000 | +5.8% | 9,823 | 0.0% | 0.05% | +39.4% | |
| NUVA | NUVASIVE INC | $386,000 | -13.3% | 7,850 | 0.0% | 0.04% | +15.4% | |
| JNJ | JOHNSON & JOHNSON | $384,000 | +0.3% | 2,161 | 0.0% | 0.04% | +32.4% | |
| BAX | BAXTER INTERNATIONAL INC | $381,000 | -17.2% | 5,929 | 0.0% | 0.04% | +7.3% | |
| TAK | TAKEDA PHARMACEUTICAL CO | $360,000 | -1.9% | 25,630 | 0.0% | 0.04% | +31.2% | |
| SNY | SANOFI-SYNTHELABO | $333,000 | -2.3% | 6,650 | 0.0% | 0.04% | +30.0% | |
| ICUI | ICU MEDICAL INC | $335,000 | -26.2% | 2,039 | 0.0% | 0.04% | -2.5% | |
| UHS | UNIVERSAL HEALTH SERVICES INC CLASS B | $206,000 | -30.6% | 2,050 | 0.0% | 0.02% | -7.7% | |
| JYNT | Exit | THE JOINT CORP | $0 | – | -56,498 | -100.0% | -0.18% | – |
| MEIP | Exit | MEI PHARMA INC | $0 | – | -4,525,034 | -100.0% | -0.24% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -45,205 | -100.0% | -0.33% | – |
| STRO | Exit | SUTRO BIOPHARMA INC | $0 | – | -1,672,497 | -100.0% | -1.21% | – |
| XENT | Exit | INTERSECT ENT INC | $0 | – | -699,235 | -100.0% | -1.73% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.